The propolis and boric acid can be highly suitable, alone/or as a combinatory approach on ovary ischemia-reperfusion injury

Purpose Ovarian ischemia-reperfusion (IR) damage continues to be a serious infertility problem. The oxidative stress plays central role in the development of IR injuries. Activation of antioxidants decreases IR injuries; however, the efficacy of antioxidant agents remains controversial. Unfortunatel...

Full description

Saved in:

Bibliographic Details
Published in:	Archives of gynecology and obstetrics Vol. 300; no. 5; pp. 1405 - 1412
Main Authors:	Geyikoglu, Fatime, Koc, Kubra, Erol, Huseyin Serkan, Colak, Suat, Ayer, Hafize, Jama, Shukri, Eser, Gizem, Dortbudak, Muhammed Bahaeddin, Saglam, Yavuz Selim
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer Berlin Heidelberg 01-11-2019 Springer Nature B.V
Subjects:	Animals Anti-Infective Agents - pharmacology Anti-Infective Agents - therapeutic use Boric Acids - pharmacology Boric Acids - therapeutic use Endocrinology Female Gynecologic Endocrinology and Reproductive Medicine Gynecology Human Genetics Injuries Ischemia Medicine Medicine & Public Health Obstetrics/Perinatology/Midwifery Ovary - drug effects Ovary - pathology Oxidative stress Propolis - pharmacology Propolis - therapeutic use Rats Rats, Sprague-Dawley Reperfusion Injury - drug therapy Reperfusion Injury - pathology Rodents Tumor necrosis factor-TNF Ischemia-reperfusion Ovary Boric acid Inflammation Propolis Oxidative stress/antioxidant activity
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Purpose Ovarian ischemia-reperfusion (IR) damage continues to be a serious infertility problem. The oxidative stress plays central role in the development of IR injuries. Activation of antioxidants decreases IR injuries; however, the efficacy of antioxidant agents remains controversial. Unfortunately, there has been no evidence for medicinal use of boric acid (BA) and propolis (Prop) on ovarian IR injury on rats so far. This study will provide to reveal the potential applications of the Prop and BA in ovarian IR therapy. Methods The Sprague–Dawley rats were randomized into five groups: I—control, II—IR, 3 h of ischemia and 3 h of reperfusion, III and IV—a signal dose of oral BA (7 mg/kg) and Prop (100 mg/kg) alone 1 h before induction of IR, V—Prop and BA together 1 h before induction of IR. SOD (superoxide dismutase), CAT (catalase), GSH (glutathione), MPO (myeloperoxidase), MDA (malondialdehyde), and IL-6 (interleukin-6) levels were quantified by ELISA and the TNF-α (tumor necrosis factor-α), 8-OHdG (8-hydroxylo-2′-deoxyguanosin) and Caspase-3 expressions were performed by immunohistochemical analyses. Results BA and Prop pretreatment significantly reduced MPO, MDA, and IL-6 levels and pathologic score in IR rats, with no effects in control group. These agents used in therapy also decreased TNF-α, 8-OHdG and Caspase-3 protein expressions increased by IR. Furthermore, BA and Prop combination showed significant ameliorative effects on ovary injury caused by IR through acting as an antioxidant, anti-inflammatory and antiapoptotic agent. Conclusion BA and Prop alone and especially in combination could be developed as therapeutic agents against ovary IR injury.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0932-0067 1432-0711
DOI:	10.1007/s00404-019-05303-9